A Neuromechanical Model-Based Strategy to Estimate the Operator's Payload in Industrial Lifting Tasks.

One of the main technological barriers hindering the development of active industrial exoskeleton is today represented by the lack of suitable payload estimation algorithms characterized by high accuracy and low calibration time. The knowledge of the payload enables exoskeletons to dynamically provide the required assistance to the user. This work proposes a payload estimation methodology based on personalized Electromyography-driven musculoskeletal models (pEMS) combined with a payload estimation method we called "delta torque" that allows the decoupling of payload dynamical properties from human dynamical properties.

Toward autonomous robotic prostate biopsy: a pilot study.

Purpose: We present the validation of PROST, a robotic device for prostate biopsy. PROST is designed to minimize human error by introducing some autonomy in the execution of the key steps of the procedure, i.e.

Actuation Selection for Assistive Exoskeletons: Matching Capabilities to Task Requirements.

Selecting actuators for assistive exoskeletons involves decisions in which designers usually face contrasting requirements. While certain choices may depend on the application context or design philosophy, it is generally desirable to avoid oversizing actuators in order to obtain more lightweight and transparent systems, ultimately promoting the adoption of a given device. In many cases, the torque and power requirements can be relaxed by exploiting the contribution of an elastic element acting in mechanical parallel.

Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.

Precision medicine in oncology requires an accurate characterization of a tumor molecular profile for patient stratification. Though targeted deep sequencing is an effective tool to detect the presence of somatic sequence variants, a significant number of patient specimens do not meet the requirements needed for routine clinical application. Analysis is hindered by contamination of normal cells and inherent tumor heterogeneity, compounded with challenges of dealing with minute amounts of tissue and DNA damages common in formalin-fixed paraffin-embedded (FFPE) specimens.